These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16797788)

  • 1. Phospholipase D1 is associated with amyloid precursor protein in Alzheimer's disease.
    Jin JK; Ahn BH; Na YJ; Kim JI; Kim YS; Choi EK; Ko YG; Chung KC; Kozlowski PB; Min do S
    Neurobiol Aging; 2007 Jul; 28(7):1015-27. PubMed ID: 16797788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipase D1 is up-regulated in the mitochondrial fraction from the brains of Alzheimer's disease patients.
    Jin JK; Kim NH; Lee YJ; Kim YS; Choi EK; Kozlowski PB; Park MH; Kim HS; Min do S
    Neurosci Lett; 2006 Oct; 407(3):263-7. PubMed ID: 16973278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Swedish amyloid precursor protein mutation increases cell cycle-related proteins in vitro and in vivo.
    Ahn KW; Joo Y; Choi Y; Kim M; Lee SH; Cha SH; Suh YH; Kim HS
    J Neurosci Res; 2008 Aug; 86(11):2476-87. PubMed ID: 18438935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
    Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
    Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease.
    Grimm MO; Kuchenbecker J; Rothhaar TL; Grösgen S; Hundsdörfer B; Burg VK; Friess P; Müller U; Grimm HS; Riemenschneider M; Hartmann T
    J Neurochem; 2011 Mar; 116(5):916-25. PubMed ID: 21214572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease.
    Ryoo SR; Cho HJ; Lee HW; Jeong HK; Radnaabazar C; Kim YS; Kim MJ; Son MY; Seo H; Chung SH; Song WJ
    J Neurochem; 2008 Mar; 104(5):1333-44. PubMed ID: 18005339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the APP promoter in Alzheimer's disease: cell type-specific expression of the beta-amyloid precursor protein.
    Lahiri DK; Ge YW
    Ann N Y Acad Sci; 2004 Dec; 1030():310-6. PubMed ID: 15659812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid precursor protein mRNA levels in Alzheimer's disease brain.
    Preece P; Virley DJ; Costandi M; Coombes R; Moss SJ; Mudge AW; Jazin E; Cairns NJ
    Brain Res Mol Brain Res; 2004 Mar; 122(1):1-9. PubMed ID: 14992810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of amyloid precursor protein reduces epsilon protein kinase C levels.
    Liron T; Seraya CB; Ish-Shalom M; Souroujon MC; Neumann D
    Neuroscience; 2007 Apr; 146(1):152-9. PubMed ID: 17321053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAG-1M is up-regulated in hippocampus of Alzheimer's disease patients and associates with tau and APP proteins.
    Elliott E; Laufer O; Ginzburg I
    J Neurochem; 2009 May; 109(4):1168-78. PubMed ID: 19317853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid precursor protein interacts with notch receptors.
    Oh SY; Ellenstein A; Chen CD; Hinman JD; Berg EA; Costello CE; Yamin R; Neve RL; Abraham CR
    J Neurosci Res; 2005 Oct; 82(1):32-42. PubMed ID: 16118793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease.
    Majercak J; Ray WJ; Espeseth A; Simon A; Shi XP; Wolffe C; Getty K; Marine S; Stec E; Ferrer M; Strulovici B; Bartz S; Gates A; Xu M; Huang Q; Ma L; Shughrue P; Burchard J; Colussi D; Pietrak B; Kahana J; Beher D; Rosahl T; Shearman M; Hazuda D; Sachs AB; Koblan KS; Seabrook GR; Stone DJ
    Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17967-72. PubMed ID: 17098871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sp3 and sp4 transcription factor levels are increased in brains of patients with Alzheimer's disease.
    Boutillier S; Lannes B; Buée L; Delacourte A; Rouaux C; Mohr M; Bellocq JP; Sellal F; Larmet Y; Boutillier AL; Loeffler JP
    Neurodegener Dis; 2007; 4(6):413-23. PubMed ID: 17934324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic domain of the beta-amyloid protein precursor of Alzheimer's disease: function, regulation of proteolysis, and implications for drug development.
    Kerr ML; Small DH
    J Neurosci Res; 2005 Apr; 80(2):151-9. PubMed ID: 15672415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel cytosolic RING finger protein dactylidin is up-regulated in brains of patients with Alzheimer's disease.
    von Rotz RC; Kins S; Hipfel R; von der Kammer H; Nitsch RM
    Eur J Neurosci; 2005 Mar; 21(5):1289-98. PubMed ID: 15813938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.
    Vaisid T; Kosower NS; Katzav A; Chapman J; Barnoy S
    Neurochem Int; 2007; 51(6-7):391-7. PubMed ID: 17513017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its activity at the surface of neural cells.
    Schmidt C; Lepsverdize E; Chi SL; Das AM; Pizzo SV; Dityatev A; Schachner M
    Mol Psychiatry; 2008 Oct; 13(10):953-69. PubMed ID: 17726461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential distribution of Alzheimer's amyloid precursor protein family variants in human sperm.
    Fardilha M; Vieira SI; Barros A; Sousa M; Da Cruz e Silva OA; Da Cruz e Silva EF
    Ann N Y Acad Sci; 2007 Jan; 1096():196-206. PubMed ID: 17405931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
    Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
    Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.